Engineered immunomodulatory extracellular vesicles derived from epithelial cells acquire capacity for positive and negative T cell co-stimulation in cancer and autoimmunity

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Biochemistry

Cancer Oncology

Immunology

Cd80

Show all topics

DOI

10.1101/2023.11.02.565371

License

CC-BY-NC-ND

Other Formats

PDF